Actualités Leica Biosystems

SEATTLE, USA and MELBOURNE, AUSTRALIA. March 1st Leica Biosystems continues to advance its relationship with NanoString Technologies Inc., supporting translational research to build confidence in reproducibility and throughput while minimizing manual steps and reducing hands-on time with the…

Solution enables laboratory managers to optimize their tissue processor workflow. NUSSLOCH, GERMANY, FEB 1, 2022. Leica Biosystems is proud to add a new offering to its dualretort tissue processor portfolio: the HistoCore PEGASUS is now available in North American geographies. Building on more than…

CAMBRIDGE, MASS., JANUARY 31, 2022. Companion diagnostic supports patient identification and enrollment into clinical trials of Leap Therapeutics‘ DKK1 inhibitor, DKN-01 Leica Biosystems, a cancer diagnostics company, has entered into an agreement with Leap Therapeutics (Nasdaq: LPTX), a…

By Chad Salinas, Vice President, AI and Machine Learning Artificial Intelligence is exponentially increasing its impact on healthcare. As deep learning is mastering computer vision tasks, its application to digital pathology is natural, with the promise of aiding in routine reporting and…

Leica Biosystems is on track to align its portfolio of instrumentation and consumables with the In Vitro Diagnostics Regulation (IVDR) that comes into effect May of 2022. Internal technical and operations teams, in partnership with Quality & Regulatory Affairs, are taking steps to ensure that…

VISTA, CA –June 17, 2021 – Leica Biosystems, the global leader in pathology workflow solutions, announced today that its Next Generation Aperio GT 450 DX scanner now supports DICOM imaging. Working closely in partnership with Leeds Teaching Hospital NHS as part of the National Pathology Imaging Co-…

Leica Biosystems, a global leader in pathology workflow solutions, becomes a diamond sponsor and announces the start of a collaboration with the European Society for Digital and Integrative Pathology (ESDIP) to promote digital pathology adoption across Europe. "Building bridges between industry and…

NEW YORK, NY and VISTA, CALIF. – April 23, 2021 — Paige, a global leader in AI-based digital diagnostics, and Leica Biosystems, a globally recognized cancer diagnostics and workflow solution leader, today announced a strategic partnership to expand access to computational pathology…

Imagine the possibilities for your Chromogenic Multiplex with Leica Biosystems and Cell IDx To accelerate the discovery journey in cancer research, Leica Biosystems has partnered with Cell IDx, a technology leader in multiplexed cellular immunodiagnostics, developing highly sensitive and specific…

Research-use-only RNA-ISH probes now available for COVID-19 on our automated platform Leica Biosystems, in partnership with Bio-Techne Corporation, announces the automation of RNAscope™ COVID-19 probes’ on BOND RX*, its staining platform, for research use only. Researchers now have the capability…